Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pathogenic bacteria in the gastrointestinal tract are diverse groups of microorganisms that cause disease by colonizing the gut mucosa and producing toxins or invading host tissues. Notable examples include Escherichia coli pathotypes such as enterotoxigenic E. coli (ETEC), enterohemorrhagic E. coli (EHEC), enteropathogenic E. coli (EPEC), enteroinvasive E. coli (EIEC), Shigella species causing dysentery, Salmonella species causing gastroenteritis and typhoid fever, Listeria monocytogenes affecting immunocompromised individuals, Campylobacter jejuni causing diarrhea and abdominal pain[1][3][5]. These organisms are transmitted via contaminated food or water and direct contact with infected individuals or animals[1][3]. They can cause symptoms ranging from mild diarrhea to life-threatening conditions such as hemolytic-uremic syndrome due to EHEC infection. Therapeutic targeting involves antibiotics tailored to the specific pathogen’s susceptibility profile and supportive care measures like hydration therapy[2][4]. The emergence of antibiotic-resistant strains poses significant challenges in treatment. *Note: This entry describes a group rather than an individual molecule/receptor.*
Inhibition of bacterial cell wall synthesis (e.g., beta-lactams), inhibition of protein synthesis (e.g., macrolides), inhibition of DNA replication (e.g., fluoroquinolones), disruption of cell membrane function[1][4]. Vaccines may induce immune response to prevent infection.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pathogenic bacteria in gastrointestinal tract.